CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NOISOFF. The owner is based in CHENGDU.

NO. 2, 2/F, BLDG 1, NO. 3 SHENXIANSHU

WEST, RD.,HIGH-TECH DIST.,

CHENGDU 610095 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NOISOFF
NOISOFF
Registered 2020

Trademark Classifications

CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. have?

CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. file in?

CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD.'s most well-known trademarks?

CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as NOISOFF. These are among 1 currently registered trademark in the portfolio.

What is CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD.'s trademark registration success rate?

CHENGDU MOBIWUSI NETWORK TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.